Cite
APA Citation
van Bommel, P. E., He, Y., Schepel, I., Hendriks, M. A. J. M., Wiersma, V. R., van Ginkel, R. J., van Meerten, T., Ammatuna, E., Huls, G., Samplonius, D. F., Helfrich, W., & Bremer, E. (2018). cD20-selective inhibition of CD47-SIRPα "don't eat me" signaling with a bispecific antibody-derivative enhances the anticancer activity of daratumumab, alemtuzumab and obinutuzumab. Oncoimmunology, 7, . http://access.bl.uk/ark:/81055/vdc_100054856240.0x00000a